2011
DOI: 10.1016/j.acra.2010.12.010
|View full text |Cite
|
Sign up to set email alerts
|

Cerebral Magnetic Resonance Spectroscopy at 7 Tesla

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
2
0
3

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 18 publications
0
2
0
3
Order By: Relevance
“…Previous studies revealed functional abnormalities of SAD patients in prefrontal cortex, ACC, and limbic/paralimbic regions which comprised corticolimbic circuitry and participated in the genesis of fear and anxiety [13][15]. In addition, thalamus and striatum abnormalities were also found in SAD patients, suggesting that these nuclei may also be involved in the pathogenesis of SAD [16], [17].…”
Section: Introductionmentioning
confidence: 98%
“…Previous studies revealed functional abnormalities of SAD patients in prefrontal cortex, ACC, and limbic/paralimbic regions which comprised corticolimbic circuitry and participated in the genesis of fear and anxiety [13][15]. In addition, thalamus and striatum abnormalities were also found in SAD patients, suggesting that these nuclei may also be involved in the pathogenesis of SAD [16], [17].…”
Section: Introductionmentioning
confidence: 98%
“…NAA alone had no effect on ThT fluorescence (Supporting Figure 1). A NAA concentration of 15mM was chosen for all subsequent experiments based on numerous studies showing NAA concentrations above 10mM (Baslow, 2003; Glodzik et al, 2015; Grams et al, 2011; Inglese et al, 2008).…”
Section: Resultsmentioning
confidence: 99%
“…Die MR-Spektroskopie (MRS) erlaubt die Charakterisierung und Quantifizierung von Metaboliten im menschlichen Gehirn, da in Abhängigkeit von der Molekülbindung der Protonen eines Gewebes lokale Magnetfeldunterschiede entstehen, die als Unterschiede der Resonanzfrequenz messbar sind (87). MR-Spektren erleichtern die Differenzialdiagnose von Hirntumoren, Metastasen, entzündlichen und metabolischen ZNS-Erkrankungen (16).…”
Section: Mr-spektroskopieunclassified